Genmab A/S Adjustments For Finance Income
Genmab A/S (GNMSF) reported Adjustments For Finance Income of $408.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFinanceIncome · last filed 2026-02-17
DKK
| Period end | Adjustments For Finance Income 6 month | Adjustments For Finance Income 12 month |
|---|---|---|
| 2024-12-31 | 4.44B DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 1.99B DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 1.94B DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 738.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 3.19B DKK 6-K · filed 2025-02-12 |
USD
| Period end | Adjustments For Finance Income 6 month | Adjustments For Finance Income 12 month |
|---|---|---|
| 2025-12-31 | $408.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $253.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $645.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $284.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $299.00M 20-F · filed 2026-02-17 |